Influence of thyroid autoimmunity at various clinical stages of hypothyroidism on the risk of miscarriage before 20 weeks of gestation

Hormones (Athens). 2023 Dec;22(4):587-593. doi: 10.1007/s42000-023-00474-2. Epub 2023 Aug 22.

Abstract

Purpose: We aimed to clarify the influence of thyroid autoantibodies at various clinical stages of hypothyroidism on the risk of pregnancy loss before 20 weeks of gestation.

Methods: We enrolled 230 pregnant women with a history of recurrent miscarriage. Detailed clinical history, physical examination, and laboratory testing of thyroid function, antithyroid peroxidase (anti-TPO), and antithyroglobulin (anti-TG) were applied among all participants.

Results: Coexisting overt hypothyroidism and positive thyroid autoantibodies quadrupled the risk of miscarriage in women before 20 weeks of gestation (OR 4.04, 95% CI = 2.08-7.96, P < 0.001). Women with subclinical hypothyroidism (OR 1.44, 95% CI = 0.81-2.57, P = 0.132,) or who were euthyroid (OR 1.53, 95% CI = 0.86-2.73, P = 0.094) showed a non-significant risk of miscarriage even with positive thyroid autoantibodies. Thyroid-stimulating hormone (TSH) was positively correlated with the number of miscarriages rather than anti-TPO (P < 0.001 and 0.209, respectively).

Conclusion: Coexistence of overt hypothyroidism and thyroid autoimmunity was the only significant driver of pregnancy loss before 20 weeks of gestation.

Keywords: Hypothyroidism; Miscarriage; Pregnancy; Thyroid autoantibodies.

MeSH terms

  • Abortion, Spontaneous*
  • Autoantibodies
  • Autoimmunity
  • Female
  • Humans
  • Hypothyroidism* / diagnosis
  • Pregnancy
  • Thyrotropin

Substances

  • Autoantibodies
  • Thyrotropin